NYSEMKT: CLDI
Calidi Biotherapeutics Inc Stock Ownership - Who owns Calidi Biotherapeutics?

Insider buying vs selling

Have Calidi Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Allan CamaisaCEO and Chairman of the Board2024-12-1710,000$1.62
$16.20kSell
Allan CamaisaCEO and Chairman of the Board2024-09-2670,155$1.15
$80.68kBuy
James A. SchoeneckDirector2024-06-03375,000$0.20
$75.00kBuy
James A. SchoeneckDirector2024-06-03173,000$0.20
$34.60kBuy
James A. SchoeneckDirector2024-04-18375,000$0.40
$150.00kBuy

1 of 1

CLDI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CLDI insiders and whales buy or sell their stock.

CLDI Shareholders

What type of owners hold Calidi Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Allan Camaisa68.56%8,965,668$12.19MInsider
James A. Schoeneck15.57%2,035,668$2.77MInsider
Scott Leftwich15.18%1,985,417$2.70MInsider
First Light Acquisition Group LLC14.77%1,931,852$2.63MInsider
Polar Asset Management Partners Inc6.59%861,800$1.17MInsider
Thomas A. Vecchiolla5.42%708,792$963.96kInsider
Stephen Thesing3.61%471,544$641.30kInsider
Boris Radoslavov Minev3.25%424,458$577.26kInsider
Santidrian Antonio Fernandez2.51%327,788$445.79kInsider
Tony T. Kalajian2.13%278,790$379.15kInsider

1 of 3

CLDI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CLDI4.66%95.34%Net BuyingNet Selling
MEIP12.05%87.95%Net Buying
KAPA3.08%52.20%Net BuyingNet Buying
FBRX11.74%88.26%Net BuyingNet Buying
ATHA29.58%32.13%Net BuyingNet Selling

Calidi Biotherapeutics Stock Ownership FAQ

Who owns Calidi Biotherapeutics?

Calidi Biotherapeutics (NYSEMKT: CLDI) is owned by 6.96% institutional shareholders, 142.52% Calidi Biotherapeutics insiders, and 0.00% retail investors. Allan Camaisa is the largest individual Calidi Biotherapeutics shareholder, owning 8.97M shares representing 68.56% of the company. Allan Camaisa's Calidi Biotherapeutics shares are currently valued at $12.19M.

If you're new to stock investing, here's how to buy Calidi Biotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.